Overview

A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.

Status:
Completed

Trial end date:
2009-03-31

Target enrollment:

Participant gender:

Summary

This study is the first study in humans to assess the safety and tolerability of various doses of GSK1292263 alone, and taken with sitigliptan.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline